isopentenyladenosine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bifulco, M; Di Matola, T; Laezza, C; Malfitano, AM; Ricchi, P | 1 |
| Ghidoni, R; Gorincioi, E; Rajabi, M; Santaniello, E; Signorelli, P | 1 |
2 other study(ies) available for isopentenyladenosine and Breast Neoplasms
| Article | Year |
|---|---|
Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 2; Cytochromes c; Female; Humans; Isopentenyladenosine; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction | 2010 |
Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle analysis and DNA-binding study.
Topics: Absorption; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA; Humans; Isopentenyladenosine; Spectrum Analysis; Stereoisomerism | 2010 |